Assisted Reproductive Technology (ART) Market size was $22.31 billion for 2015 and is predicted to be evaluated at $31.41 billion by end of forecast period registering CAGR of 4.4%.
ART is a modern technique used to treat infertility. The procedures included in it are gamete intrafallopian transfer (GIFT), in vitro fertilization (IVF), zygote intrafallopian transfer (ZIFT) and intracytoplasmic sperm injection (ICSI). In vitro fertilization (IVF) is the leading method in which eggs and sperms are combined in laboratory and fertilized eggs are transferred into uterus of woman. IVF process includes stimulation of ovaries, egg recovery, fertilization, embryo culture and transfer of embryo.
GIFT (Gamete intrafallopian transfer)is a methodin which gametes are transferred into fallopian tube of woman and fertilization takes place in fallopian tubes. The method is performed only if fallopian tubes are functioning normally. In ZIFT (zygote intrafallopian transfer) fertilization occurs in laboratory instead of fallopian tube and fertilized eggs are moved to fallopian tube instead of uterus. ICSI (intracytoplasmic sperm injection) is a technique in which sperm is directly inserted into matured egg. In U.S ICSI methodis very popular and leads ART methods.
View a summary of the “Assisted Reproductive Technology (ART) Market Size, Industry Analysis Report” @ https://www.gminsights.com/industry-analysis/assisted-reproductive-technology-market
The industry is segmented into fresh donor segment and frozen non-donor segment.
Fresh donor segment exceeded $1.3 billion revenue mark for 2015 and is predicted to register more than 5% CAGR during forecast timeframe. The proportion of donor eggs used in assisted reproductive technology cycles grows with age. As per CDC (Centers for Disease Control and Prevention), the kind of ART (assisted reproductive technology) cycles differ with woman’s age. These cycles where woman uses own eggs is mostly dominated by young women.For instance, 97.01% of women below 35 years of age used their own eggs for fertilization.
Frozen non-donor segment is predicted to register CAGR of 5.8% during forecast timeframe.
APAC assisted reproductive technology market share contributed more than 19% of total revenue and is predicted to register CAGR of 6.1% during forecast timeframe. Rapid growth in healthcare sector in nations like Japan, China and India is predicted to promote industry expansion during forecast period.
North America assisted reproductive technologymarketsize was evaluated at more than $9 billion for 2015 and is anticipated to be evaluated at greater than $11 billion by end of 2023. It is predicted to register CAGR of about 2.7% during forecast timeframe. Rise in infertility owing to fatness and demographical changes have fuelled expansion of North America assisted reproductive technology industry.
Europe assisted reproductive technology market contributed more than 22.51% of the total revenue share and is predicted to register a CAGR of 2.7% during forecast timeframe.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/506
Key industry players profiled in the report include Vitro Life, Research Instruments,Thermo Fisher Scientific Incorporation, Irvine scientific, Genea Limited,Research Instruments, IVFtech ApS, Origio a/s, Esco Micro Private Limited, Cook Medicaland Smiths Medical.
Author Name : Dhananjay Punekar